In-vitro slime production by <i>Staphylococcus epidermidis</i> in presence of subinhibitory concentrations of ciprofloxacin, ofloxacin and sparfloxacin

Pérez-Giraldo, Ciro; Rodríguez-Benito, A.; Morán, F. J.; Hurtado, C.; Blanco, M. T.; Gómez-García, A. C.

doi:10.1093/jac/33.4.845

Cited by 20 publications

(22 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The inability of sub-MICs of moxifloxacin to diminish biofilm formation was observed. No data exist in this respect, but these results are in accordance with those previously reported with other fluoroquinolones [14,15]. However, other authors observed that sub-MICs (1/2, 1/4 or 1/8 MIC) of ciprofloxacin significantly reduced the OD of the biofilm layer of S. epidermidis [16].…”

Section: Discussionsupporting

confidence: 86%

Moxifloxacin and Biofilm Production by Coagulase-Negative Staphylococci

et al. 2004

Self Cite

View full text Add to dashboard Cite

The in vitro activity of moxifloxacin against 41 strains of coagulase-negative staphylococci was determined. A relationship between the activity of moxifloxacin and biofilm formation was detected. Biofilm-producing strains were more resistant to moxifloxacin than biofilm-negative strains. Our global results obtained with six strains of Staphylococcus epidermidis showed that subinhibitory concentrations of moxifloxacin did not significantly modify biofilm formation. On the other hand, moxifloxacin concentrations of 2, 10, 50 and 100 × MIC produced a log decrease in viable count (included in a biofilm) of 0.20, 0.37, 1.10 and 1.69, respectively.

show abstract

Section: Discussionsupporting

confidence: 86%

Moxifloxacin and Biofilm Production by Coagulase-Negative Staphylococci

et al. 2004

Self Cite

View full text Add to dashboard Cite

show abstract

“…Norfloxacin, ciprofloxacin, ofloxacin and azithromycin at sub inhibitory concentrations reduced the glycocalyx production and inhibited the adherence of Staphylococcus epidermidis and Pseudomonas aeruginosa (Pézer-Giraldo et al, 1989 ;Yassien et al, 1995). Ciprofloxacin was reported to eradicate the performed biofilms of P. aeruginosa (Reid et al, 1994).…”

Section: A Antimicrobial Agentsmentioning

confidence: 99%

Application of Scanning Electron Microscopy for the Morphological Study of Biofilm in Medical Devices

El-Baky¹

2012

Scanning Electron Microscopy

View full text Add to dashboard Cite

“…Ag + , Zn 2+ , Mg 2+ , Cu 2+ ) have been used in conjunction with polymers. Nanoparticles loaded with these metal ions showed higher activity against E. coli, Salmonella choleraesuis, Salmonella typhimurium and S. aureus which suggests that the antibacterial activity is [135,[136][137][138][139] related to the zeta potential of the compound. Th e most commonly studied metal used together with chitosan, is Ag.…”

Section: Antimicrobial Studiesmentioning

confidence: 99%

Chitosan as an Advanced Healthcare Material

Jardine

Sayed

2014

Advanced Biomaterials and Biodevices

View full text Add to dashboard Cite

Chitin and chitosan are renewable biopolymers with inherently favourable properties allowing diverse chemical modifi cation that generates novel materials ideal for biomedical applications. Chitin itself has very poor aqueous solubility and hence found limited utility. For this reason the use of chitosan, in particular, modifi ed chitosan, has increased exponentially in biomedical applications in recent years. Th e review of chitosan as a health care material includes wound healing or tissue regeneration, drug delivery and antimicrobial studies. Specialist applications are vast and due to the shortened publication process, biomedical applications of chitosan may warrant more frequent reviews.In this review, highlights of recent research on the synthesis and analysis of chitin and chitosan based nanomaterials and nanofi bres will be covered. A detailed review of the synthetic transformation of chitosan that further added value by enabling diverse application has been discussed. Th e value of copolymerization and graft ing of biodegradable synthetic polymers with chitosan in order to improve stability and control of the functional biomaterial has been a major driver in the biotechnological innovation.

show abstract

In-vitro slime production by Staphylococcus epidermidis in presence of subinhibitory concentrations of ciprofloxacin, ofloxacin and sparfloxacin

Cited by 20 publications

References 0 publications

Moxifloxacin and Biofilm Production by Coagulase-Negative Staphylococci

Moxifloxacin and Biofilm Production by Coagulase-Negative Staphylococci

Application of Scanning Electron Microscopy for the Morphological Study of Biofilm in Medical Devices

Chitosan as an Advanced Healthcare Material

Contact Info

Product

Resources

About